Design and rationale of FOCUS (PX-171-011): A randomized,...

BMC Cancer 2012 / 12 Vol. 12; Iss. 1

Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)

Roman Hájek, Richard Bryce, Sunhee Ro, Barbara Klencke, Heinz Ludwig
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
DOI:
10.1186/1471-2407-12-415
Date:
December, 2012
File:
PDF, 167 KB
english, 2012
Conversion to is in progress
Conversion to is failed